Beta-HCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: Implications for breast carcinogenesis?

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 2, 2009, Pages 191-195

  Hudelist, Gernot ^a   Wuelfing, Pia ^b   Czerwenka, Klaus ^a   Knöfler, Martin ^a   Haider, Sandra ^a   Fink Retter, Anneliese ^a   Gschwantler Kaulich, Daphne ^a   Pfeiler, Georg ^a   Kubista, Ernst ^a   Singer, Christian F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Breast cancer; DCIS; HCG receptor; Invasive

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; LUTEINIZING HORMONE RECEPTOR;

ARTICLE; BREAST; BREAST TUMOR; CANCER INVASION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; POSTMENOPAUSE;

BREAST; BREAST NEOPLASMS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; POSTMENOPAUSE; RECEPTORS, LH;

EID: 65849452705     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-008-0458-3     Document Type: Article

References (20)

1. Bocker W, Decker T, Ruhnke M, Schneider W (1997) Ductal hyperplasia and ductal carcinoma in situ. Definition-classification- differential diagnosis. Pathologe 18:3-18. doi:10.1007/s002920050191
2. Dufau ML (1998) The luteinizing hormone receptor. Annu Rev Physiol 60:461-496. doi:10.1146/annurev.physiol.60.1.461
3. Han SW, Lei ZM, Rao CV (1996) Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin in mucosal cells from human fallopian tubes. Endocrinology 137:2929-2937. doi:10.1210/en.137.7.2929
4. Hudelist G, Huber A, Knoefler M, et al (2008) Human chorionic gonadotropin/ luteinizing hormone receptor (HCG/LH-R) expression in eutopic endometrium and endometriotic implants: evidence for HCG sensitivity of endometriosis. Reprod Sci 15(6):543-551
5. Kuorelahti A, Rulli S, Huhtaniemi I, Poutanen M (2007) Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Endocrinology 148:3694-3703. doi:10.1210/en.2007-0249
6. Lei ZM, Reshef E, Rao V (1992) The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab 75:651-659. doi:10.1210/jc.75.2.651
7. Lei ZM, Toth P, Rao CV, Pridham D (1993a) Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 77:863-872. doi:10.1210/jc.77.3.863
8. Lei ZM, Rao CV, Lincoln SR, Ackermann DM (1993b) Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis. J Clin Endocrinol Metab 76:763-768. doi:10.1210/jc.76.3.763
9. Licht P, Russu V, Lehmeyer S, Wildt L (2001) Molecular aspects of direct LH/hCG effects on human endometrium-lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol 1:10-19
10. Licht P, von Wolff M, Berkholz A, Wildt L (2003) Evidence for cycledependent expression of full-length human chorionic gonadotropin/ luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril 79(Suppl 1):718-723. doi:10.1016/S0015-0282(02)04822-7
11. Lin J, Lei ZM, Lojun S, Rao CV, Satyaswaroop PG, Day TG (1994) Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 79:1483-1491. doi:10.1210/jc.79.5.1483
12. Lojun S, Bao S, Lei ZM, Rao CV (1997) Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol Reprod 57:1202-1210. doi:10.1095/biolreprod57.5.1202
13. Mann RJ, Keri RA, Nilson JH (2003) Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulationinduced pathophysiology. Recent Prog Horm Res 58:343-375. doi:10.1210/rp.58.1.343
14. Minegishi T, Tano M, Abe Y, Nakamura K, Ibuki Y, Miyamoto K (1997) Expression of luteinizing hormone/human chorionic gonadotrophin (LH/HCG) receptor mRNA in the human ovary. Mol Hum Reprod 3:101-107. doi:10.1093/molehr/ 3.2.101
15. Piersma D, Berns EM, Verhoef-Post M et al (2006) A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. J Clin Endocrinol Metab 91:1470-1476. doi:10.1210/jc.2005-2156
16. Popnikolov N, Yang J, Liu A, Guzman R, Nandi S (2001) Reconstituted normal human breast in nude mice: effect of host pregnancy environment and human chorionic gonadotropin on proliferation. J Endocrinol 168:487-496. doi:10.1677/joe.0.1680487
17. Rao Ch V, Li X, Manna SK, Lei ZM, Aggarwal BB (2004) Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation. J Biol Chem 279:25503-25510. doi:10.1074/jbc.M400683200
18. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138-140
19. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I (2002) Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143:4084-4095. doi:10.1210/en.2002-220490
20. Shemesh M, Mizrachi D, Gurevich M et al (2001) Expression of functional luteinizing hormone (LH) receptor and its messenger ribonucleic acid in bovine endometrium: LH augmentation of cAMP and inositol phosphate in vitro and human chorionic gonadotropin (hCG) augmentation of peripheral prostaglandin in vivo. Reprod Biol 1:13-32